Atlassian Corporation (TEAM) Stock Forecast
Data as of May 2, 2026Technology · Current price $89.80 (+30.94%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 16, 2026 | Keith Weiss | Morgan Stanley | $120.00 | +33.6% |
| Mar 12, 2026 | Alex Zukin | Wolfe Research | $100.00 | +11.4% |
| Mar 12, 2026 | Greg Moskowitz | Mizuho Securities | $185.00 | +106.0% |
| Feb 6, 2026 | Keith Bachman | BMO Capital | $130.00 | +44.8% |
| Feb 6, 2026 | Gregg Moskowitz | Mizuho Securities | $205.00 | +128.3% |
| Feb 6, 2026 | Jason Celino | KeyBanc | $170.00 | +89.3% |
| Feb 6, 2026 | David Hynes | Canaccord Genuity | $185.00 | +106.0% |
| Feb 6, 2026 | Ryan MacWilliams | Wells Fargo | $155.00 | +72.6% |
| Feb 6, 2026 | Karl Keirstead | UBS | $105.00 | +16.9% |
| Feb 4, 2026 | Keith Bachman | BMO Capital | $135.00 | +50.3% |
| Dec 16, 2025 | Allan Verkhovski | BTIG | $220.00 | +145.0% |
| Oct 31, 2025 | Thomas Blakey | Cantor Fitzgerald | $240.00 | +167.3% |
| Oct 31, 2025 | Rob Owens | Piper Sandler | $300.00 | +234.1% |
| Oct 31, 2025 | Rob Oliver | Robert W. Baird | $230.00 | +156.1% |
| Oct 31, 2025 | Joel Fishbein Jr | Truist Financial | $210.00 | +133.9% |
| Oct 31, 2025 | Kash Rangan | Goldman Sachs | $260.00 | +189.5% |
| Oct 24, 2025 | Keith Bachman | BMO Capital | $190.00 | +111.6% |
| Oct 23, 2025 | Jason Celino | KeyBanc | $210.00 | +133.9% |
| Aug 8, 2025 | Joel Fishbein | Truist Financial | $230.00 | +156.1% |
| Aug 8, 2025 | Adam Tindle | Raymond James | $250.00 | +178.4% |
Top Analysts Covering TEAM
TEAM vs Sector & Market
| Metric | TEAM | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.08 | 2.34 | 2.41 |
| Analyst Count | 36 | 13 | 18 |
| Target Upside | +53.4% | +4072.6% | +14.9% |
| P/E Ratio | -97.04 | 28.06 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $6.32B | $6.37B | $6.42B | 23 |
| 2026-09-30 | $1.69B | $1.70B | $1.74B | 8 |
| 2026-12-31 | $1.84B | $1.85B | $1.90B | 8 |
| 2027-03-31 | $1.94B | $1.96B | $2.01B | 8 |
| 2027-06-30 | $1.94B | $1.95B | $2.00B | 8 |
| 2027-09-30 | $1.99B | $2.01B | $2.06B | 11 |
| 2027-12-31 | $2.15B | $2.17B | $2.22B | 8 |
| 2028-03-31 | $2.27B | $2.29B | $2.35B | 10 |
| 2028-06-30 | $2.26B | $2.28B | $2.34B | 7 |
| 2029-06-30 | $9.77B | $9.93B | $10.12B | 11 |
| 2030-06-30 | $10.79B | $10.97B | $11.17B | 20 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $4.42 | $4.75 | $4.97 | 17 |
| 2026-09-30 | $1.16 | $1.17 | $1.21 | 13 |
| 2026-12-31 | $1.37 | $1.39 | $1.43 | 10 |
| 2027-03-31 | $1.48 | $1.50 | $1.54 | 9 |
| 2027-06-30 | $1.42 | $1.43 | $1.47 | 8 |
| 2027-09-30 | $1.40 | $1.42 | $1.46 | 8 |
| 2027-12-31 | $1.61 | $1.63 | $1.68 | 16 |
| 2028-03-31 | $1.72 | $1.73 | $1.79 | 16 |
| 2028-06-30 | $1.69 | $1.71 | $1.76 | 11 |
| 2029-06-30 | $7.61 | $7.77 | $7.96 | 3 |
| 2030-06-30 | $8.74 | $8.93 | $9.14 | 2 |
Frequently Asked Questions
What is the analyst consensus for TEAM?
The consensus among 36 analysts covering Atlassian Corporation (TEAM) is Buy with an average price target of $177.89.
What is the highest price target for TEAM?
The highest price target for TEAM is $505.00, set by Keith Weiss at Morgan Stanley on 2022-02-10.
What is the lowest price target for TEAM?
The lowest price target for TEAM is $100.00, set by Alex Zukin at Wolfe Research on 2026-03-12.
How many analysts cover TEAM?
36 analysts have issued ratings for Atlassian Corporation in the past 12 months.
Is TEAM a buy or sell right now?
Based on 36 analyst ratings, TEAM has a consensus rating of Buy (2.08/5) with a +53.4% upside to the consensus target of $177.89.
What are the earnings estimates for TEAM?
Analysts estimate TEAM will report EPS of $4.75 for the period ending 2026-06-30, with revenue estimated at $6.37B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.